CDC: Prepare for rebound in TB cases post-pandemic
By
Alicia Lasek
Mar 21, 2022
A 20% decline in tuberculosis cases in 2020 may be followed by an uptick once the COVID-19 pandemic wanes, according to CDC investigators. Clinicians should be prepared to detect cases and control spread,...
Orthostatic intolerance common in post-acute patients, signaling need for clinical workup
By
Alicia Lasek
Sep 02, 2021
Older rehabilitation patients should be assessed for symptoms of orthostatic intolerance upon admission, a new study suggests.
Recent falls can worsen fracture risk among women, study finds
By
Alicia Lasek
Jan 09, 2020
Older women who report recent falls are more likely fracture a bone in the next five years. Injurious falls are linked to the most severe risk.
Bone health intervention cuts fracture risk in men treated for prostate cancer: study
By
Alicia Lasek
Apr 05, 2022
Early intervention with bone mineral density screening may help prevent major fractures in older men treated with androgen deprivation therapy, investigators say.
Nurses ask feds to invoke Defense Production Act for N95 masks; survey finds ‘unacceptable’ reuse...
By
Alicia Lasek
Sep 04, 2020
One in three nurses remain short on supplies, an ANA survey has found. “Re-use and decontamination of single-use PPE as the ‘new normal’ is unacceptable, given the lack of standards and evidence...
Hearing loss may take ‘enormous’ toll on elders’ quality of life, study says
By
Alicia Lasek
Jul 20, 2019
Hearing loss is linked to significant mental, physical and social ailments in seniors, especially memory loss, a large new study has found.
FDA expands use of remdesivir to skilled nursing, other non-hospital settings
By
Alicia Lasek
Jan 25, 2022
Remdesivir, the first FDA-approved COVID-19 drug, now can be used in adult and pediatric patients with mild-to moderate COVID-19 illness at high risk of progressing to severe disease, the agency has announced.
Monoclonal antibodies excel in treating COVID-19 breakthrough cases, Mayo Clinic says
By
Alicia Lasek
Nov 19, 2021
Monoclonal antibody treatment lowers the odds of hospitalization by 77% in patients with COVID-19 breakthrough infections, investigators say. These SARS-CoV-2 reinfections have become more common in long-term...
An antibody cocktail that halts disease progression in sick COVD-19 patients has been shown to prevent the disease altogether in healthy people who live in close contact with an infected person, the drugmaker...
Becerra orders CMS to rethink $22 Medicare Part B premium price hike tied to Aduhelm
By
Alicia Lasek
Jan 11, 2022
With the 50% price drop of Aduhelm on January 1, there is good reason for CMS to reassess a hefty proposed premium hike for 2022, the U.S. health secretary said. On Wednesday, CMS is expected to announce...